Estimates Revisions MannKind Corporation
Equities
MNKD
US56400P7069
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.280 USD | -2.38% |
|
+14.69% | -42.15% |
| 05-07 | MannKind Corporation, Q1 2026 Earnings Call, May 06, 2026 | |
| 05-06 | Earnings Flash (MNKD) MannKind Corporation Posts Q1 Adjusted Loss $0.02 per Share | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- MNKD Stock
- Consensus MannKind Corporation
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition